Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs387906223
rs387906223
T 0.700 CausalMutation CLINVAR

dbSNP: rs1801177
rs1801177
LPL
0.010 GeneticVariation BEFREE Subjects with combined hyperlipidemia (CHL) were screened for mutations in the lipoprotein lipase (LPL) gene by single-strand conformational polymorphism, and a previously reported G-->A DNA sequence change in exon 2, causing substitution of Asp by Asn at position 9, was identified in 2 individuals. 7749858

1995

dbSNP: rs1217691063
rs1217691063
0.010 GeneticVariation BEFREE Hyperhomocysteinemia, serum folate levels and both C677T and A1298C MTHFR mutations are associated with CVD in HD patients. 12187094

2002

dbSNP: rs397507444
rs397507444
0.010 GeneticVariation BEFREE Hyperhomocysteinemia, serum folate levels and both C677T and A1298C MTHFR mutations are associated with CVD in HD patients. 12187094

2002

dbSNP: rs1695
rs1695
0.020 GeneticVariation BEFREE The GSTP1 Ile(105)Val polymorphism was associated in a dose-dependent fashion with an improved failure-free survival in patients with Hodgkin's lymphoma (P = 0.02). 15788664

2005

dbSNP: rs3135932
rs3135932
0.010 GeneticVariation BEFREE The IL10RA Ser138Gly variant was underrepresented among lymphoma cases (odds ratio (OR)=0.81, 95 per cent confidence interval (95% CI)=0.65-1.02), mainly owing to an inverse association with Hodgkin's lymphoma (HL). 16971956

2006

dbSNP: rs4986790
rs4986790
0.010 GeneticVariation BEFREE Furthermore, the TLR4 Asp299Gly variant was positively associated with the risk of mucosa-associated lymphoid tissue lymphoma (OR=2.76, 95% CI=1.12-6.81) and HL (OR=1.80, 95% CI=0.99-3.26). 16971956

2006

dbSNP: rs77375493
rs77375493
0.010 GeneticVariation BEFREE JAK2 V617F mutation is uncommon in non-Hodgkin lymphomas. 16321863

2006

dbSNP: rs4918
rs4918
0.010 GeneticVariation BEFREE In contrast with previous reports, this study suggests that CKD patients on HD treatment have a similar polymorphism distribution of the AHSG gene compared with the normal population and that the reduction in serum fetuin-A levels in Italian HD patients is not associated with an alteration in the distribution of AHSG T256S polymorphisms. 17851232

2007

dbSNP: rs4746
rs4746
0.020 GeneticVariation BEFREE Our aim was to study A419C (E111A) single nucleotide polymorphism (SNP) of the glyoxalase I gene in hemodialysis (HD) patients. 18079478

2008

dbSNP: rs397507545
rs397507545
0.010 GeneticVariation BEFREE We describe the previously unreported condition of Hodgkin's lymphoma in a patient with Noonan syndrome caused by germ-line mutations (1507G > C, Gly503Arg) in exon 13 of the PTPN11 gene. 18758896

2008

dbSNP: rs1801157
rs1801157
0.010 GeneticVariation BEFREE The single-nucleotide polymorphism (SNP) rs1801157 (previously known as CXCL12-A/ stromal cell-derived factor-1 (SDF1)-3'A) in CXCL12/SDF1 gene was assessed in breast cancer, Hodgkin's lymphoma (HL), and non-Hodgkin's lymphoma (NHL), since the chemokine CXCL12, previously known as SDF1, and its receptor CXCR4 regulate leukocyte trafficking and many essential biological processes, including tumor growth, angiogenesis, and metastasis of different types of tumors. 19927352

2009

dbSNP: rs25487
rs25487
0.010 GeneticVariation BEFREE A positive association was found for XRCC1 gene polymorphism Arg399Gln (OR, 1.77; 95% confidence interval [95% CI], 1.16-2.71) and risk of HD. 19280628

2009

dbSNP: rs759412116
rs759412116
0.010 GeneticVariation BEFREE A positive association was found for XRCC1 gene polymorphism Arg399Gln (OR, 1.77; 95% confidence interval [95% CI], 1.16-2.71) and risk of HD. 19280628

2009

dbSNP: rs1432295
rs1432295
G 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs1432295
rs1432295
G 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs2019960
rs2019960
G 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs2019960
rs2019960
G 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs2608053
rs2608053
G 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs2608053
rs2608053
G 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs501764
rs501764
C 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs501764
rs501764
C 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs6903608
rs6903608
G 0.800 GeneticVariation GWASDB A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs6903608
rs6903608
G 0.800 GeneticVariation GWASCAT A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568

2010

dbSNP: rs4746
rs4746
0.020 GeneticVariation BEFREE The A419C (E111A) polymorphism of the GLO I gene is associated with vascular disease in hemodialysis (HD) patients and some RAGE gene polymorphisms are implicated in various pathological states. 20185929

2010